Nanoviricides Analyst Ratings
EF Hutton Reiterates Buy on Nanoviricides, Maintains $6.5 Price Target
Nanoviricides Analyst Ratings
EF Hutton Assumes Nanoviricides at Buy, Announces Price Target of $5.25
Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Cardio Diagnostics Holdings (CDIO)
EF Hutton Reiterates Buy on Nanoviricides, Maintains $5.25 Price Target
EF Hutton Lowers Price Target on NanoViricides to $5.25 From $8.50, Maintains Buy Rating
EF Hutton Maintains Buy on Nanoviricides, Lowers Price Target to $5.25